1984
DOI: 10.1515/jom-1984-840214
|View full text |Cite
|
Sign up to set email alerts
|

Diethylstilbestrol exposure in utero: Review of literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
0
0
Order By: Relevance
“…The primary indication for diethylstilbestrol prescription was, however, both the prevention of miscarriage in pregnant women and the treatment of menopause and estrogen-deficiency symptoms. The administration of this molecule in pregnant women shows the potential to correlate with a variety of structural abnormalities on the progeny, including congenital genitourinary abnormalities in males, such as varicocele, cryptorchidism and testicular hypoplasia, which can lead to infertility [56].…”
Section: Discussionmentioning
confidence: 99%
“…The primary indication for diethylstilbestrol prescription was, however, both the prevention of miscarriage in pregnant women and the treatment of menopause and estrogen-deficiency symptoms. The administration of this molecule in pregnant women shows the potential to correlate with a variety of structural abnormalities on the progeny, including congenital genitourinary abnormalities in males, such as varicocele, cryptorchidism and testicular hypoplasia, which can lead to infertility [56].…”
Section: Discussionmentioning
confidence: 99%
“…Some studies have provided novel insight into the molecular basis for spermiation failure and apoptosis caused by 17beta-estradiol and also offer new mechanisms by which adult exposure to environmental estrogens can affect spermatogenesis and fertility [24]. Studies on boys delivered by mothers treated with diethylstilbestrol, a very potent estrogen agonist from 1950 to 1970, have reported alterations in sperm quality and higher incidence of genital malformations, cryptorchidism, and testicular cancer compared to the control population [25][26]. Estrogenic drugs administered by injections, oral gavage, or via drinking water have been claimed to result in varied effects such as decreased Sertoli cell number, Leydig cell hyperplasia, decreased sperm count and testicular weight [27][28].…”
Section: Introductionmentioning
confidence: 99%